On the 31st of August @TheFlorey held the 2023 Florey Awards. We are proud to say that our group head, @hmakhter , was awarded the 'Pathway To Impact Award' in commemoration of his chemical developments towards improving Relaxin and Insulin based therapeutics.
Earlier this year we published our work on lipidation of B7-33, our single chain H2 relaxin analogue; showing a dramatic improvement in stability and retained activity. check it out here: https://t.co/lZjPW75Ta9 @TheFlorey
We have been hard at work on relaxin 2 minimization and stabilization attempts, please check out our latest publication - Further Developments towards a Minimal Potent Derivative of Human Relaxin-2 in IJMS https://t.co/pErNpM0Zet @TheFlorey
Congratulations to our talented first year PhD student @hongkang598 for winning the best student presentation at the winter PUG symposium! Watch this space for more excellent work from Him!
🧬A cutting-edge discovery from The Florey's @HossainLab has solved a long-standing problem in peptide based drug development - paving the way for new treatments in a range of conditions.
Find out how our researchers solved the floppy peptide problem: https://t.co/0kTC9NoBq6
���